Volume 10, Issue 6 (4-2012)                   IJRM 2012, 10(6): 537-542 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Sasannejad P, Mellat Ardekani A, Velayati A, Shoeibi A, Saeidi M, Foroughipour M et al . Cerebral vein thrombosis in women using short course oral contraceptive consumption. IJRM 2012; 10 (6) :537-542
URL: http://ijrm.ir/article-1-328-en.html
Cerebral vein thrombosis in women using short course oral contraceptive consumption
Payam Sasannejad1 , Ali Mellat Ardekani * 2, Arash Velayati1 , Ali Shoeibi1 , Morteza Saeidi1 , Mohsen Foroughipour1 , Mahmoud Reza Azarpazhooh1
1- Department of Neurology, Ghaem Medical Center, Mashhad University of Medical Sciences, Mashhad, Iran
2- Department of Neurology, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran , ali_mellat@ssu.ac.ir
Abstract:   (2309 Views)
Background: Muslim women tend to postpone their menstrual period using short course oral contraceptives (OC) during Ramadan, Muslims fasting month. Recently, many cases of stroke, particularly cerebral vein thrombosis (CVT), have been reported in Ramadan.
Objective: This work studies the incidence of CVT and its relation to Ramadan.
Materials and Methods: This is a cohort study conducted from October 2006 to October 2009 and included 4 consecutive Ramadan’s. All patients with definite diagnosis of CVT who were referred to the neurology department of Ghaem Hospital, Mashhad, Iran in this four-year period were included in the study.
Results: During the study period, 70 cases with CVT (11 males and 59 females) were recruited. Twenty five cases were admitted during Ramadan months which was significantly higher than all the other 32 months (p=1.9×10-7). The higher frequency of females (6 times more) among CVT cases probed by investigating possible risk factors and short term OC consumption was revealed as the major risk factor (p=0.00071).
Conclusion: Higher incidence of CVT in females during Ramadan suggests the presence of specific risk factors in this group. Our study revealed that short-term use of OCs may be a major risk factor for CVT.
Keywords: Cerebral vein thrombosis, Oral contraceptives, Menstruation, Ramadan.
Full-Text [PDF 358 kb]   (572 Downloads) |   |   Full-Text (HTML)  (284 Views)  
Type of Study: Original Article |
References
1. Galazios G, Tsikouras P, Liberis V, Koutlaki N, Vlachos G, Teichmann AT, et al. Attitudes towards contraception in three different populations. Clin Exp Obstet Gynecol 2008; 35: 22-26.
2. Mosher WD, Martinez GM, Chandra A, Abma JC, Willson SJ. Use of contraception and use of family planning services in the United States: 1982-2002. Adv Data 2004; 10: 1-36.
3. Lee J, Jezewski MA. Attitudes toward oral contraceptive use among women of reproductive age: a systematic review. ANS Adv Nurs Sci 2007; 30: 85-103. [DOI:10.1097/00012272-200701000-00016]
4. Srikanthan A, Reid RL. Religious and cultural influences on contraception. J Obstet Gynaecol Can 2008; 30: 129-137. [DOI:10.1016/S1701-2163(16)32736-0]
5. Sueyoshi S, Al-Khozahe HO, Ohtsuka R, Effects of reproduction norms on contraception practice among Muslim women in Amman, Jordan. Eur J Contracept Reprod Health Care 2006; 11: 138-145. [DOI:10.1080/13625180500539430]
6. Hogan D, Biratu B. Social identity and community effects on contraceptive use and intentions in southern Ethiopia. Stud Fam Plann 2004; 35: 79-90. [DOI:10.1111/j.1728-4465.2004.00010.x]
7. Kridli SA, Newton SE. Jordanian married Muslim women's intentions to use oral contraceptives. Int Nurs Rev 2005; 52: 109-114. [DOI:10.1111/j.1466-7657.2005.00260.x]
8. Comerasamy H, Read B, Francis C, Cullings S, Gordon H. The acceptability and use of contra-ception: A prospective study of Somalian women's attitudes. J Obstet Gynaecol 2003; 23: 412-415. [DOI:10.1080/01443610310001209342]
9. Cebeci Save D, Erbaydar T, Kalaca S, Harmanci H, Cali S, Karavus M. Resistance against contraception or medical contraceptive methods: a qualitative study on women and men in Istanbul. Eur J Contracept Reprod Health Care 2004; 9: 94-101. [DOI:10.1080/13625180410001715663]
10. Azarpazhooh MR, Rafi S, Etemadi MM, Khadem N, Fazlinejad A. The relation between short-term oral contraceptive consumption and cerebrovascular, cardiovascular disorders in Iranian women attending Hajj. Saudi Med J 2008; 29: 1024-1027.
11. Saidee M, Froghipoor M, Sasannejad P, Mellat Ardakani A, Azarpazhooh MR. The relation between short course oral contraceptive consumption and cerebral vein thrombosis in Ramadan. Iran J Neurol 2008; 7: 260-265.
12. Farmer RDT, Preston TD. The risk of venous thromboembolism associated with low oestrogen oral contraceptives. J Obstet Gynaecol 1995; 15: 195-200. [DOI:10.3109/01443619509015499]
13. WHO collaborative study of cardiovascular disease and steroid hormone contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet 1995; 346: 1575-1582. [DOI:10.1016/S0140-6736(95)91926-0]
14. Spitzer WO, Lewis MA, Heinemann LAJ, Thorogood M, MacRae KD. On behalf of transnational research group on oral contraceptives and the health of young women. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. BMJ 1996; 312: 83-88. [DOI:10.1136/bmj.312.7023.83]
15. Scoditti U, Buccino GP, Pini M, Pattacini C, Mancia D. Risk of acute cerebrovascular events related to low oestrogen oral contraceptive treatment. Ital J Neurol Sci 1998; 19: 15-19. [DOI:10.1007/BF03028806]
16. Siritho S, Thrift AG, McNeil JJ, You RX, Davis SM, Donnan GA, et al. Risk of ischemic stroke among users of the oral contraceptive pill: The Melbourne Risk Factor Study (MERFS) Group. Stroke 2003; 34: 1575-1580. [DOI:10.1161/01.STR.0000077925.16041.6B]
17. Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453-1457. [DOI:10.1016/S0140-6736(94)90286-0]
18. Wysokinska EM, Wysokinski WE, Brown RD, Karnicki K, Gosk-Beirska I, Grill D, et al. Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis. Neurology 2008; 70: 627-633. [DOI:10.1212/01.wnl.0000297195.97325.a8]
19. Hillier CE, Collins PW, Bowen DJ, Bowley S, Wiles CM. Inherited prothrombotic risk factors and cerebral venous thrombosis. QJM 1998; 91: 677-680. [DOI:10.1093/qjmed/91.10.677]
20. de Bruijn SF, Stam J, Koopman MM, Vandenbroucke JP.Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users who are carriers of hereditary prothrombotic conditions. BMJ 1998; 316: 589-592. [DOI:10.1136/bmj.316.7131.589]
21. Dentali F, Crowther M, Ageno W. Thrombophilic abnormalities, oral contraceptive, and risk of cerebral vein thrombosis: a meta-analysis. Blood 2006; 107: 2766-2773. [DOI:10.1182/blood-2005-09-3578]
22. Bousser MG, Russell RR. Cerebral Venous Thrombosis. London: WB Saunders, 1997.
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb